The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
EULAR recommendations for the management of Behçet disease
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis, P., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.011742 · Cited by 2,048
Zhang, W., Doherty, M., Bardin, T., Pascual, E., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055269 · Cited by 1,407
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Combe, B., Landewe, R., Lukas, C., Bolosiu, H. D., Breedveld, F., Dougados, M., Emery, P., Ferraccioli, G., Hazes, J. M. W., Klareskog, L., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044354 · Cited by 786
Self-citationZhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.-P., Hauselmann, H. J., Herrero-Beaumont, G., Jordan, K., Kaklamanis, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028886 · Cited by 785
Kural-Seyahi, E., Fresko, I., Seyahi, N., Ozyazgan, Y., Mat, C., Hamuryudan, V., Yurdakul, S., & Yazici, H. (2003) · Medicine · doi:10.1097/00005792-200301000-00006 · Cited by 768
Self-citationBertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
A Controlled Trial of Azathioprine in Behçet's Syndrome
Yazici, H., Pazarli, H., Barnes, C. G., Tüzün, Y., Özyazgan, Y., Silman, A., Serdaroğlu, S., Oğuz, V., Yurdakul, S., Lovatt, G. E., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002013220501 · Cited by 647
Self-citationHellmich, B., Flossmann, O., Gross, W. L., Bacon, P., Willem Cohen-Tervaert, J., Guillevin, L., Jayne, D., Mahr, A., Merkel, P. A., Raspe, H., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062711 · Cited by 633
Self-citationZhang, W., Doherty, M., Pascual, E., Bardin, T., Barskova, V, Conaghan, P., Gerster, J., Jacobs, J., Leeb, B., Lioté, F., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.055251 · Cited by 584
Pendleton, A., Arden, N., Dougados, M., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Cluzeau, F., Cooper, C., Dieppe, P. A., Günther, K.-P., et al. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.12.936 · Cited by 575
Masuda, K., Urayama, A., Kogure, M., Nakajima, A., Nakae, K., & Inaba, G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92381-7 · Cited by 490
Hamuryudan, V., Mat, C., Saip, S., Ozyazgan, Y., Siva, A., Yurdakul, S., Zwingenberger, K., & Yazici, H. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00004 · Cited by 456
Self-citationYazici, H., Tüzün, Y., Pazarli, H., Yurdakul, S., Ozyazgan, Y., Ozdoğan, H., Serdaroğlu, S., Ersanli, M., Ulkü, B. Y., & Müftüoğlu, A. U. (1984) · Annals of the Rheumatic Diseases · doi:10.1136/ard.43.6.783 · Cited by 411
Self-citationA double-blind trial of colchicine in Beh�et's syndrome
Yurdakul, S., Mat, C., T�z�n, Y., �zyazgan, Y., Hamuryudan, V., Uysal, �., ?enocak, M., & Yazici, H. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200111)44:11<2686::aid-art448>3.0.co;2-h · Cited by 383
Self-citationOhno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Sugita, S., Ueno, S., Yoshizaki, K., & 稲葉, 午. (2004) · PubMed · Cited by 343
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations
Sfikakis, P. P., Markomichelakis, N., Alpsoy, E., Assaad-Khalil, S., Bodaghi, B., Gul, A., Ohno, S., Pipitone, N., Schirmer, M., Stanford, M., et al. (2007) · Rheumatology · doi:10.1093/rheumatology/kem034 · Cited by 301
Self-citationAzathioprine in Behçet's syndrome. Effects on long‐term prognosis
Hamuryudan, V., Özyazgan, Y., Hizli, N., Mat, C., Yurdakul, S., Tüzün, Y., Şlenocak, M., & Yazici, H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400425 · Cited by 280
Self-citationKotter, I. (2003) · British Journal of Ophthalmology · doi:10.1136/bjo.87.4.423 · Cited by 274
Alpsoy, E., Durusoy, C., Yilmaz, E., Ozgurel, Y., Ermis, O., Yazar, S., & Basaran, E. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.4.467 · Cited by 273
Infliximab for Recurrent, Sight-Threatening Ocular Inflammation in Adamantiades–Behçet Disease
Sfikakis, P. P., Kaklamanis, P. H., Elezoglou, A., Katsilambros, N., Theodossiadis, P. G., Papaefthimiou, S., & Markomichelakis, N. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-5-200403020-00025 · Cited by 229
Self-citationThe use of interferon α in behçet disease: review of the literature
Kötter, I., Günaydin, I., Zierhut, M., & Stübiger, N. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.09.010 · Cited by 226
Self-citationDougados, M., Betteridge, N., Burmester, G. R., Euller-Ziegler, L., Guillemin, F., Hirvonen, J., Lloyd, J., Ozen, S., Da Silva, J. A. P., Emery, P., et al. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.023697 · Cited by 214
Bodaghi, B., Gendron, G., Wechsler, B., Terrada, C., Cassoux, N., Thi Huong, D. L., Lemaitre, C., Fradeau, C., LeHoang, P., & Piette, J.-C. (2007) · British Journal of Ophthalmology · doi:10.1136/bjo.2006.101550 · Cited by 198
Self-citationEffectiveness of cyclosporin therapy for Beh¸let's disease
Nussenblatt, R. B., Palestine, A. G., Chan, C., Mochizuki, M., & Yancey, K. B. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780280611 · Cited by 188
Hassard, P. V., Binder, S. W., Nelson, V., & Vasiliauskas, E. A. (2001) · Gastroenterology · doi:10.1053/gast.2001.22556 · Cited by 176
Results of interferon-alfa therapy in patients with Behçet uveitis
Tuğal-Tutkun, İ., Güney-Tefekli, E., & Urgancıoğlu, M. (2006) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-006-0346-y · Cited by 143
A double-blind trial of depot corticosteroids in Behçet's syndrome
Mat, C., Yurdakul, S., Uysal, S., et al. (2005) · Lara D. Veeken · doi:10.1093/rheumatology/kei165 · Cited by 106
Self-citationAppraisal of Guidelines Research & Evaluation:AGREE Instrument
Wu, W. (2007) · Journal of Evidence-Based Medicine · Cited by 96
Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome
Hamuryudan, V., Mat, C., Saip, S., et al. (1998) · Annals of Internal Medicine · Cited by 91
Interferon alfa combined with azathioprine for the uveitis of Behçet's disease: an open study.
Hamuryudan, V., Özyazgan, Y., Fresko, Y., et al. (2002) · PubMed · Cited by 78
Çalgünerı, M., Öztürk, M. A., Ertenli, İ., Kiraz, S., Apraş, Ş., & Özbalkan, Z. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.5.492 · Cited by 74
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease
Triolo, G., Vadalà, M., Accardo-Palumbo, A., Ferrante, A., Ciccia, F., Giardina, E., Citarrella, P., Lodato, G., & Licata, G. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.6.560 · Cited by 69
Efficacy of TNF blockade in cyclophosphamide resistant neuro-Behcet disease
Ribi, C., Sztajzel, R., Delavelle, J., & Chizzolini, C. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.055434 · Cited by 69
Infliximab for the Treatment of Posterior Uveitis with Retinal Neovascularization in Behçet Disease
Giansanti, F., Barbera, M. L., Virgili, G., Pieri, B., Emmi, L., & Menchini, U. (2004) · European Journal of Ophthalmology · doi:10.1177/112067210401400515 · Cited by 65
Efficacy and safety of systemic recombinant interferon‐alpha in Behcet's disease
Georgiou, Monastirli, Pasmatzi, Gartaganis, Goerz, & Tsambaos (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00159.x · Cited by 63
Kram, M. T., May, L. D., Goodman, S., & Molinas, S. (2003) · Diseases of the Colon & Rectum · doi:10.1007/s10350-004-6506-4 · Cited by 61
Interferon therapy for Behçet's disease
Alpsoy, E., Yılmaz, E., & Başaran, E. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70226-8 · Cited by 55
Low Dose Cyclosporin-A Therapy in Behcet's Disease
Sajjadi, H., Soheilian, M., Ahmadieh, H., et al. (1994) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1994.10.553 · Cited by 40
Cited by
Neuro-Behçet's disease: epidemiology, clinical characteristics, and management
Al-Araji, A., & Kidd, D. P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70015-8 · Cited by 491
Diagnosis and management of Neuro-Behçet’s disease: international consensus recommendations
Kalra, S., Silman, A., Akman-Demir, G., Bohlega, S., Borhani-Haghighi, A., Constantinescu, C. S., Houman, H., Mahr, A., Salvarani, C., Sfikakis, P. P., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-013-7209-3 · Cited by 345
Self-citationBehçet's disease – a contemporary review
Mendes, D., Correia, M., Barbedo, M., Vaio, T., Mota, M., Gonçalves, O., & Valente, J. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.011 · Cited by 320
How I treat recurrent venous thromboembolism in patients receiving anticoagulant therapy
Schulman, S. (2017) · Blood · doi:10.1182/blood-2017-03-742304 · Cited by 62
Metadata
- Authors
- Hatemi, G., Silman, A., Bang, D., Bodaghi, B., Chamberlain, A. M., Gul, A., Houman, M. H., Kötter, I., Olivieri, I., Salvarani, C., Sfikakis, P. P., Siva, A., Stanford, M. R., Stübiger, N., Yurdakul, S., & Yazici, H.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 67
- Issue
- 12
- Pages
- 1656-1662
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2143190437
- Cited by
- 718
- References
- 39
- FWCI
- 41.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.